XFOR stock forecast
Our latest prediction for X4 Pharmaceuticals, Inc.'s stock price was made on the Oct. 5, 2020 when the stock price was at 7.33$.
In the short term (2weeks), XFOR's stock price should underperform the market by -3.85%. During that period the price should oscillate between -10.90% and +13.04%.
In the medium term (3months), XFOR's stock price should underperform the market by -7.41%. During that period the price should oscillate between -42.14% and +31.29%.Get email alerts
Create a solid portfolio with XFOR
About X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -2.62$ per share.
The book value per share is 8.01$
Three months stock forecastOct. 5, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|